US Patent 7666622 Monomeric self-associating fusion polypeptides and therapeutic uses thereof
Patent 7666622 was granted and assigned to Regeneron Pharmaceuticals, Inc. on February, 2010 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7666622 Monomeric self-associating fusion polypeptides and therapeutic uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
